Biosynex (ALBIO) — Strategic Asset Allocation Index
Biosynex (ALBIO) has a Strategic Asset Allocation Index of 28.4% as of June 2025. Strategic assets (PP&E of €12.59 Million plus long-term investments of €-) total €12.59 Million, measured against net assets of €44.31 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Biosynex Strategic Asset Allocation Index (2010–2024)
This chart shows how Biosynex's Strategic Asset Allocation Index has evolved across 15 annual periods from 2010 to 2024. As of June 2025, the index stands at 28.4%, representing strategic assets of €12.59 Million against net assets of €44.31 Million EUR. Explore ALBIO cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Biosynex (2010–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Biosynex from 2010 to 2024, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Biosynex worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 18.5% | €14.85 Million | €14.85 Million | €- | €80.50 Million | ▲ +5.5 pp |
| 2023 | 13.0% | €16.10 Million | €16.10 Million | €- | €124.31 Million | ▲ +7.7 pp |
| 2022 | 5.2% | €8.74 Million | €8.74 Million | €- | €166.76 Million | ▲ +2.1 pp |
| 2021 | 3.1% | €5.26 Million | €5.26 Million | €- | €167.81 Million | ▼ -0.4 pp |
| 2020 | 3.6% | €2.36 Million | €2.36 Million | €- | €66.29 Million | ▲ +1.7 pp |
| 2019 | 1.9% | €579.67K | €579.67K | €- | €30.38 Million | ▼ -1.5 pp |
| 2018 | 3.4% | €1.00 Million | €460.40K | €543.79K | €29.26 Million | ▼ -2.1 pp |
| 2017 | 5.5% | €1.59 Million | €482.95K | €1.11 Million | €28.91 Million | ▲ +0.3 pp |
| 2016 | 5.2% | €1.27 Million | €494.61K | €775.54K | €24.36 Million | ▼ -48.5 pp |
| 2015 | 53.8% | €11.36 Million | €489.07K | €10.87 Million | €21.13 Million | ▼ -11.3 pp |
| 2014 | 65.1% | €2.25 Million | €407.00K | €1.84 Million | €3.45 Million | ▼ -10.3 pp |
| 2013 | 75.4% | €2.98 Million | €445.00K | €2.54 Million | €3.96 Million | ▲ +70.9 pp |
| 2012 | 4.5% | €232.00K | €232.00K | €- | €5.18 Million | ▲ +2.4 pp |
| 2011 | 2.1% | €109.00K | €109.00K | €- | €5.16 Million | ▼ -58.9 pp |
| 2010 | 61.0% | €76.00K | €76.00K | €- | €124.59K | — |